By Chris Elkins 
The manufacturers of endoscopes linked to superbug outbreaks failed to receive clearance before marketing their devices, failed to issue adequate cleaning instructions and failed to report adverse events. The U.S. Food and Drug Administration warned manufacturers Olympus, Pentax...
By Chris Elkins 
Prescription drug abuse reached epidemic levels in the U.S. in the last decade. As the world’s leader and trendsetter in a multitude of areas, the country has a history of setting examples for the rest of the world – both good and bad. The abuse of pharmaceuticals hasn’t...
By Chris Elkins 
Victims of transvaginal mesh injuries earned another victory over device manufacturers. C.R. Bard agreed to pay $200 million to settle roughly 3,000 cases, concluding about 20 percent of remaining lawsuits against mesh manufacturers. The settlement resolved the majority of the...
By Michelle Llamas 
Medical device giant Zimmer took a loss over the Durom Cup hip replacement system after a Los Angeles jury awarded $9.2 million to a man who says the implant caused him permanent injuries. Gary Kline, 59, filed the lawsuit against the device manufacturer after he received the...
By Chris Elkins 
It kills more people than car accidents every year. The Centers for Disease Control and Prevention (CDC) classified it as an epidemic and the World Health Organization (WHO) reported it threatened the achievements of modern medicine. Prescription drug abuse is a global problem,...
By Chris Elkins 
July marked the 50th anniversary of the Medicare and Medicaid programs, the primary funders of more than 15,000 nursing homes in the U.S. The White House’s Department of Health and Human Services used the moment to propose a major overhaul to the requirements for nursing homes...
By Michelle Llamas 
One of the first laparoscopic power morcellator lawsuits filed in federal court settled for an undisclosed amount last week before it was scheduled to reach trial. Scott Burkhart filed the lawsuit against LiNA Medical in March 2014 after his wife, Donna, died of a uterine cancer...
By Michelle Llamas 
New studies may point to more data calling Johnson & Johnson’s blockbuster blood thinner Xarelto’s safety into question – most notably the possibility of an increase in stomach bleeds and eye hemorrhaging. In the first study, Drs. Judy H. Hun and John C. Hwang reported that...
By Michelle Llamas 
The Food and Drug Administration (FDA) warned that a new class of Type 2 diabetes drugs, including Johnson & Johnson’s blockbuster Invokana, may cause a serious condition that can lead to hospitalization. J&J’s Invokana (canagliflozin) works by causing blood sugar to... Page 9 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.